A support for private practice
The Gynaecology Management Group (GMG), led by Dr Conrad Mashiloane, is actively engaged in supporting its members on all matters private practice.
GMG collaborates with SASOG to the benefit of its shared membership, with GMG focusing on business aspects and SASOG on clinical aspects. Collaborative projects include coding, peer review, medico-legal matters, and matters related to the NHI. Collaboration is also with SASOG committees, including private practice, medico-legal, BetterGYN, NHI and BetterOBS.
GMG conducts discussions and negotiations on behalf of its members individually and collectively with medical schemes, administrators, managed health care organisations, hospitals, etc.
Collective discussions usually relate to reimbursement, governance, contracts, managed care or fee-for-service proposals and coding.
Individual practices or members are advised on practice costs, forensic or profile reviews with the assistance of Healthman, issues of governance, etc.
GMG also represents its members at industry forums or other stakeholders’ meetings. GMG has representation and directorship in the South African Private Practitioners Forum (SAPPF). All GMG members are SAPPF members and fees are included in the GMG fee.
The GMG Executive Commitee:
Dr CD Mashiloane (Chairperson)
Dr JP du Buisson (CEO)
Dr JC Archer Prof G Dreyer, Dr MJC Kleynhans, Dr H Manyonga, Dr JA Margolis, Dr M van der Schyff, Dr RG White
Dr Conrad Mashiloane - Chairperson GMG
The GMG contact details:
Tel: 011 340 9000
Fax: 011 782 0270
NIPT and GEMS
GEMS Criteria for NIPT
- Intermediate/High risk first trimester or second trimester screening (i.e. 1:300 - 1:1000 or <1:300)
- AMA-Over 35 years old
- Previous affected pregnancy or child with T21, T18, T13
- Please check the cut-off for 'intermediate risk' and 'high risk' with your laboratory.
- Doctor must complete a PMB form and motivational letter and send it to GEMS.
Authorisation will take about 2 weeks
Practical Points for Obstetric Practices during COVID-19
As practitioners who primarily see patients as first line practitioners, we also need to screen patients to identify those at risk for COVID 19 infections. This can be done telephonically asking questions regarding, cough, shortness of breath, fever, headache and sore throat. If you deem patients at risk of being infected with COVID 19. You should fill out a PUI form. This can be found at the following address https://www.nicd.ac.za/diseases-a-z-index/covid-19/covid-19-resources/
The form should be sent to the patient and then the patient should be sent to your local dedicated COVID 19 testing laboratory together with a requisition form. Please contact your usual pathology provider for the list of dedicated COVID 19 testing centres. You should postpone the patients visit until these results are available. The contact tracing list on the form can be filled out by the patient. We are also going into the flu season and should not forget that pregnant patients with H1N1 are at risk for severe morbidity if they do not receive Tamiflu within 72 hours of onset of symptoms. It might be a good idea to also request that a nasofaringeal swab also be done for H1N1 at the same time.
If the patient does test positive her ante-natal visit should be postponed until she has completed self –isolation. If it is not possible to do this the patient should be seen as the last patient of the day. Contact the lead clinician at your hospital and ask on guidance regarding seeing this patient in your rooms as to the correct attire and wash down of your rooms.
By now hopefully all patients are attending their ante-natal visits on their own. Ideally you should not have more than 2 patients in your rooms at a time and they should be maintaining social distancing. The patients can for example wait in their cars until you are ready to see them.
The SASA (South African Society of Anaesthesiologists) app can also be downloaded from your app store with lots of vital information once we start running into more severe ill patients, but also some good general information is available.
Dr JP du Buisson Dr Conrad Mashiloane
CEO: GMG Chairperson: GMG